ArticleJournal of cardiothoracic surgery2026
The SGLT2 inhibitor dapagliflozin alleviates ventricular remodeling and apoptosis after myocardial infarction by inhibiting the TGF-β1 and MAPK pathways.
Zhen Zhu et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.